Literature DB >> 30505543

Pacemaker implantation after transcatheter aortic valve: why is this still happening?

Stefan Toggweiler1, Richard Kobza1.   

Abstract

During the past years, the industry and most transcatheter aortic valve operators have focused on reduction of paravalvular leaks rather than on the reduction of permanent pacemakers (PPM). However, since indication for transcatheter aortic valve implantation (TAVI) is moving toward a healthier and younger patient population, new PPMs may become more of an issue. Certain factors such as pre-existing conduction disorders or anatomical features cannot be changed. However, the amount of mechanical trauma to the conduction system and periprocedural medical management offers the potential for optimization. By optimizing our procedure, we may finally be able to achieve low, surgical-like, PPM rates.

Entities:  

Keywords:  Aortic stenosis; atrio-ventricular block; conduction disorder; permanent pacemaker (PPM)

Year:  2018        PMID: 30505543      PMCID: PMC6242925          DOI: 10.21037/jtd.2018.06.103

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN: 2072-1439            Impact factor:   2.895


  41 in total

1.  Transcatheter versus surgical aortic-valve replacement in high-risk patients.

Authors:  Craig R Smith; Martin B Leon; Michael J Mack; D Craig Miller; Jeffrey W Moses; Lars G Svensson; E Murat Tuzcu; John G Webb; Gregory P Fontana; Raj R Makkar; Mathew Williams; Todd Dewey; Samir Kapadia; Vasilis Babaliaros; Vinod H Thourani; Paul Corso; Augusto D Pichard; Joseph E Bavaria; Howard C Herrmann; Jodi J Akin; William N Anderson; Duolao Wang; Stuart J Pocock
Journal:  N Engl J Med       Date:  2011-06-05       Impact factor: 91.245

2.  Permanent pacemaker implantation following transcatheter aortic valve replacement: still a concern?

Authors:  Marina Urena; Josep Rodés-Cabau
Journal:  JACC Cardiovasc Interv       Date:  2015-01       Impact factor: 11.195

3.  Pacemaker dependency after transcatheter aortic valve implantation with the self-expanding Medtronic CoreValve System.

Authors:  Robert M A van der Boon; Nicolas M Van Mieghem; Dominic A Theuns; Rutger-Jan Nuis; Sjoerd T Nauta; Patrick W Serruys; Luc Jordaens; Ron T van Domburg; Peter P T de Jaegere
Journal:  Int J Cardiol       Date:  2013-01-05       Impact factor: 4.164

Review 4.  Visualizing anatomical evidences on atrioventricular conduction system for TAVI.

Authors:  Tomokazu Kawashima; Fumi Sato
Journal:  Int J Cardiol       Date:  2014-04-12       Impact factor: 4.164

5.  Predictors and permanency of cardiac conduction disorders and necessity of pacing after transcatheter aortic valve implantation.

Authors:  Kirsten Boerlage-Van Dijk; Kirsten M Kooiman; Ze Yie Yong; Esther M A Wiegerinck; Peter Damman; Berto J Bouma; Jan G P Tijssen; Jan J Piek; Reinoud E Knops; Jan Baan
Journal:  Pacing Clin Electrophysiol       Date:  2014-07-17       Impact factor: 1.976

6.  SOURCE 3 Registry: Design and 30-Day Results of the European Postapproval Registry of the Latest Generation of the SAPIEN 3 Transcatheter Heart Valve.

Authors:  Olaf Wendler; Gerhard Schymik; Hendrik Treede; Helmut Baumgartner; Nicolas Dumonteil; Leo Ihlberg; Franz-Josef Neumann; Giuseppe Tarantini; José Luis Zamarano; Alec Vahanian
Journal:  Circulation       Date:  2017-01-19       Impact factor: 29.690

7.  Implantation and 30-Day Follow-Up on All 4 Valve Sizes Within the Portico Transcatheter Aortic Bioprosthetic Family.

Authors:  Helge Möllmann; Axel Linke; David M Holzhey; Thomas Walther; Ganesh Manoharan; Ulrich Schäfer; Karl Heinz-Kuck; Ad J Van Boven; Simon R Redwood; Jan Kovac; Christian Butter; Lars Søndergaard; Alexander Lauten; Gerhard Schymik; Stephen G Worthley
Journal:  JACC Cardiovasc Interv       Date:  2017-08-14       Impact factor: 11.195

Review 8.  Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives.

Authors:  Vincent Auffret; Rishi Puri; Marina Urena; Chekrallah Chamandi; Tania Rodriguez-Gabella; François Philippon; Josep Rodés-Cabau
Journal:  Circulation       Date:  2017-09-12       Impact factor: 29.690

9.  Mortality risk associated with bundle branch blocks and related repolarization abnormalities (from the Women's Health Initiative [WHI]).

Authors:  Zhu-ming Zhang; Pentti M Rautaharju; Elsayed Z Soliman; Joann E Manson; Michael E Cain; Lisa W Martin; Anthony A Bavry; Laxmi Mehta; Mara Vitolins; Ronald J Prineas
Journal:  Am J Cardiol       Date:  2012-08-02       Impact factor: 2.778

10.  Repositionable Versus Balloon-Expandable Devices for Transcatheter Aortic Valve Implantation in Patients With Aortic Stenosis.

Authors:  Thomas Pilgrim; Stefan Stortecky; Fabian Nietlispach; Dik Heg; David Tueller; Stefan Toggweiler; Enrico Ferrari; Stéphane Noble; Francesco Maisano; Raban Jeger; Marco Roffi; Jürg Grünenfelder; Christoph Huber; Peter Wenaweser; Stephan Windecker
Journal:  J Am Heart Assoc       Date:  2016-11-17       Impact factor: 5.501

View more
  4 in total

Review 1.  A Disruptive Technology: Determining Need for Permanent Pacing After TAVR.

Authors:  Amneet Sandhu; Wendy S Tzou
Journal:  Curr Cardiol Rep       Date:  2021-04-16       Impact factor: 2.931

2.  Dependence on permanent pacemakers inserted after transcatheter aortic valve implantation: predictive factors in a ten-year retrospective analysis: Rates and predictors of pacemaker dependence after TAVI.

Authors:  Lance Ng; Rajesh Nair; Faeez Ali; Sanjeevan Pasupati
Journal:  AsiaIntervention       Date:  2021-12

Review 3.  The impact of advances in percutaneous catheter interventions on redo cardiac surgery.

Authors:  Dhaval Pravin Trivedi; SukeshKumar Reddy Chigarapalli; Deepak Mohan Gangahar; Venkat Ratnam Machiraju
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2020-09-19

4.  Financial Incentives for Transcatheter Aortic Valve Implantation in Ontario, Canada: A Cost-Utility Analysis.

Authors:  John K Peel; Rafael Neves Miranda; David Naimark; Graham Woodward; Mamas A Mamas; Mina Madan; Harindra C Wijeysundera
Journal:  J Am Heart Assoc       Date:  2022-04-12       Impact factor: 6.106

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.